Sort   by:  
 Page size 
UnknownRisks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Not available
S-EPMC10170303 | biostudies-literature
UnknownHeritable DNA methylation marks associated with susceptibility to breast cancer.
Not available
S-EPMC5830448 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownDexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595 | biostudies-literature
UnknownEffect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Not available
S-EPMC7556338 | biostudies-literature
UnknownMendelian randomisation study of smoking exposure in relation to breast cancer risk.
Not available
S-EPMC8505411 | biostudies-literature
UnknownIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140 | biostudies-literature
UnknownBreast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Not available
S-EPMC7675034 | biostudies-literature
UnknownAssociation of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Not available
S-EPMC10469654 | biostudies-literature
UnknownHaplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3196382 | biostudies-literature
Sort   by:  
 Page size